The stock price of Fractyl Health Inc (NASDAQ: GUTS) has dropped by -11.81 compared to previous close of 2.37. Despite this, the company has seen a fall of -13.28% in its stock price over the last five trading days. globenewswire.com reported 2024-11-12 that REMAIN-1 weight maintenance pivotal study enrollment progressing rapidly; mid-point data analysis expected in Q2 2025 Anticipate reporting data from REVEAL-1 open-label cohort beginning in Q4 2024 Topline data from REVITALIZE-1 pivotal study expected in mid-2025 Company presented compelling weight maintenance data from both Revita ® and Rejuva ® platforms at ObesityWeek ® 2024 Conference call today at 4:30 p.m. ET BURLINGTON, Mass, Nov. 12, 2024 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (“the Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and Type 2 Diabetes (T2D), today reported its third quarter 2024 financial results and provided business updates.
Is It Worth Investing in Fractyl Health Inc (NASDAQ: GUTS) Right Now?
Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for GUTS is 19.88M, and at present, short sellers hold a 9.63% of that float. On November 15, 2024, the average trading volume of GUTS was 375.16K shares.
GUTS’s Market Performance
GUTS’s stock has seen a -13.28% decrease for the week, with a -15.38% drop in the past month and a -12.55% fall in the past quarter. The volatility ratio for the week is 10.44%, and the volatility levels for the past 30 days are at 12.64% for Fractyl Health Inc The simple moving average for the past 20 days is -19.45% for GUTS’s stock, with a -59.43% simple moving average for the past 200 days.
Analysts’ Opinion of GUTS
Morgan Stanley, on the other hand, stated in their research note that they expect to see GUTS reach a price target of $18. The rating they have provided for GUTS stocks is “Overweight” according to the report published on February 27th, 2024.
BofA Securities gave a rating of “Buy” to GUTS, setting the target price at $26 in the report published on February 27th of the current year.
GUTS Trading at -19.13% from the 50-Day Moving Average
After a stumble in the market that brought GUTS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.59% of loss for the given period.
Volatility was left at 12.64%, however, over the last 30 days, the volatility rate increased by 10.44%, as shares sank -16.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -36.28% lower at present.
During the last 5 trading sessions, GUTS fell by -13.28%, in comparison to the 20-day moving average, which settled at $2.59. In addition, Fractyl Health Inc saw -83.74% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GUTS starting from Rajagopalan Harith, who sale 96,517 shares at the price of $2.47 back on Nov 11 ’24. After this action, Rajagopalan Harith now owns 491,329 shares of Fractyl Health Inc, valued at $238,358 using the latest closing price.
Caplan Jay David, the President, Chief Product Off. of Fractyl Health Inc, sale 64,197 shares at $2.47 during a trade that took place back on Nov 11 ’24, which means that Caplan Jay David is holding 153,544 shares at $158,541 based on the most recent closing price.
Stock Fundamentals for GUTS
Current profitability levels for the company are sitting at:
- -599.84 for the present operating margin
- -1.06 for the gross margin
The net margin for Fractyl Health Inc stands at -466.2. The total capital return value is set at -0.54.
Based on Fractyl Health Inc (GUTS), the company’s capital structure generated 0.29 points at debt to capital in total, while cash flow to debt ratio is standing at -1.84.
Currently, EBITDA for the company is -50.55 million with net debt to EBITDA at 0.58. When we switch over and look at the enterprise to sales, we see a ratio of 492.76. The receivables turnover for the company is 5.41for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.58.
Conclusion
To sum up, Fractyl Health Inc (GUTS) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
